ArticleFrontiers in oncology2022

MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.

Josef Horak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.